BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6385602)

  • 1. [Update on the treatment of leprosy with desoxyfructo-serotonin at Bamako].
    Mester de Parajd L
    Acta Leprol; 1984; 2(1):69-70. PubMed ID: 6385602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of 9 months of treatment of lepromatous leprosy with desoxyfructo-serotonin].
    Saint-André P; Baquillon G; Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1982; (86-87):189-97. PubMed ID: 6815988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and paraclinical evaluation of lepers at the Marchoux Institute after 12 months of treatment with desoxyfructo-serotonin].
    Baquillon G; Mester de Parajd L
    Acta Leprol; 1984; 2(1):65-8. PubMed ID: 6385601
    [No Abstract]   [Full Text] [Related]  

  • 4. Desoxyfructo-serotonin: first human metabolite with antileprosy activity.
    Mester de Parajd L; Balakrishnan S
    Acta Leprol; 1981; (83):21-6. PubMed ID: 6792854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of leprosy by human metabolites].
    Mester de Parajd L; Mester de Parajd M
    Acta Leprol; 1986; 4(3):363-72. PubMed ID: 3105224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Desoxyfructo-serotonin: its therapeutic effect in the treatment of leprosy].
    Mester de Parajd M; Ambrose EJ; Tayeb N; Antia NH
    Acta Leprol; 1989; 7 Suppl 1():200-2. PubMed ID: 2503990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyfructo-serotonin: a new drug with anti-leprosy activity.
    Mester de Parajd L; Balakrishnan S; Saint-André P; Mester de Parajd M
    Ann Microbiol (Paris); 1982; 133(3):427-32. PubMed ID: 7165215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serotonin uptake by platelets in leprosy and a new approach to prevent it.
    Szabados L; Launay JM; Mester M; Cottenot F; Pennec J; Mester L
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):42-8. PubMed ID: 7195882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali].
    Baquillon G; Ferracci C; Diallo J; Saint-Andreé P; Pattyn SR
    Acta Leprol; 1981; 85():40-52. PubMed ID: 6805234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of bacilloscopy practiced on 360 leprosy patients, treated for over 5 years by sulfone monotherapy and examined at Bamako (Mali)].
    Baquillon G; Ferracci C; Ridel PR; Saint-André P; Pattyn SR
    Acta Leprol; 1981; 85():25-39. PubMed ID: 6805233
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The training of health personnel by the Marchoux Institute in Bamako from 1979 to 1995].
    Tiendrébéogo A; Blanc L; Sylla PM; Bobin P
    Acta Leprol; 1996; 10(1):37-43. PubMed ID: 8967292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic update: leprosy and it's reactions.
    Ghosh S
    Indian J Dermatol; 1990 Mar; 35(1):57-65. PubMed ID: 2246003
    [No Abstract]   [Full Text] [Related]  

  • 14. Antileprosy and biological antioxidant activity of serotonin.
    Bergel M
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):259. PubMed ID: 7196892
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of serotonin adipinate for improving the contractile activity of the hypokinetic zone of the myocardium].
    Simonenkov AP; Kliuzhev VM; Ardashev VN; Fedorov VD; Vrublevskiĭ OIu; Chernov MIu; Savina LN
    Voen Med Zh; 2002 Jan; 323(1):31-5. PubMed ID: 11881198
    [No Abstract]   [Full Text] [Related]  

  • 17. [The concept of the clinical use of serotonin adipinate in treating surgical patients].
    Fedorov VD; Simonenkov AP
    Vestn Khir Im I I Grek; 1998; 157(3):15-9. PubMed ID: 9751961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the diagnosis and treatment of leprosy.
    Moschella SL
    J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disabilities observed in new cases of leprosy diagnosed in the Bamako district (Mali) in 1994].
    Sow SO; Tiendrebeogo A; Hamed Oould B; Lienhart C; Ponnighaus JM
    Acta Leprol; 1999; 11(4):161-70. PubMed ID: 10987047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of leprosy: science or politics?
    Naafs B
    Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.